Transplant Glomerulopathy: Morphology, Associations and Mechanism
Open Access
- 10 July 2009
- journal article
- review article
- Published by S. Karger AG in Nephron Clinical Practice
- Vol. 113 (1) , c1-c7
Abstract
Transplant glomerulopathy (TG) is a lesion with specific morphology and strong evidence of an immune mechanism. The incidence of TG is approximately 20% by 5 years after transplantation. TG is characterized by proteinuria, hypertension and declining graft function. Appearances on light microscopy include thickened capillary walls and double contours, with reduplication or lamination of the glomerular basement membrane on electron microscopy. TG is associated with acute rejection, the antibody status before transplantation and de novo HLA antibodies. HLA class II and/or donor-specific antibodies incur additional risks. Desensitization protocols do not always prevent the development of TG in highly sensitized individuals. Associations between TG, past or current C4d and the presence of alloantibodies are recognised, however, C4d in the peri-tubular capillaries or glomeruli is not a prerequisite at the time of diagnosis. Clinical observation and animal models suggest that TG arises as a consequence of chronic endothelial cell (EC) injury by the humoral arm of the immune system. In some cases, this follows a period of EC accommodation after an episode of acute injury. Proposed treatments include augmentation of background immunosuppression, and trials of monoclonal therapies targeted at CD20-positive B cells are underway.Keywords
This publication has 18 references indexed in Scilit:
- Successful Treatment of Chronic Antibody-Mediated Rejection With IVIG and Rituximab in Pediatric Renal Transplant RecipientsTransplantation, 2008
- Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat modelTransplant Immunology, 2008
- Revisiting the glomerular charge barrier in the molecular eraCurrent Opinion in Nephrology and Hypertension, 2008
- De novo membranous nephropathy associated with donor‐specific alloantibodyClinical Transplantation, 2007
- Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathyWiener klinische Wochenschrift, 2006
- Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathyKidney International, 2004
- Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejectionNephrology Dialysis Transplantation, 2001
- CONTROL OF ANTIDONOR ANTIBODY PRODUCTION WITH TACROLIMUS AND MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS WITH CHRONIC REJECTION1Transplantation, 2001
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- Transplant glomerulopathy: Evolution of morphologically distinct changesKidney International, 1985